ATE514793T1 - Zusammensetzungen und verfahren für il13- biomarker - Google Patents
Zusammensetzungen und verfahren für il13- biomarkerInfo
- Publication number
- ATE514793T1 ATE514793T1 AT06815683T AT06815683T ATE514793T1 AT E514793 T1 ATE514793 T1 AT E514793T1 AT 06815683 T AT06815683 T AT 06815683T AT 06815683 T AT06815683 T AT 06815683T AT E514793 T1 ATE514793 T1 AT E514793T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- methods
- biomarkers
- measuring
- determining biomarkers
- Prior art date
Links
- 102000003816 Interleukin-13 Human genes 0.000 title abstract 2
- 108090000176 Interleukin-13 Proteins 0.000 title abstract 2
- 239000000090 biomarker Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
- G01N2800/122—Chronic or obstructive airway disorders, e.g. asthma COPD
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72229605P | 2005-09-30 | 2005-09-30 | |
| PCT/US2006/037856 WO2007041219A2 (en) | 2005-09-30 | 2006-09-29 | Compositions and methods for il13 biomarkers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE514793T1 true ATE514793T1 (de) | 2011-07-15 |
Family
ID=37906704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06815683T ATE514793T1 (de) | 2005-09-30 | 2006-09-29 | Zusammensetzungen und verfahren für il13- biomarker |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US7875427B2 (de) |
| EP (1) | EP1943359B1 (de) |
| AT (1) | ATE514793T1 (de) |
| WO (1) | WO2007041219A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007045477A2 (en) | 2005-10-21 | 2007-04-26 | Novartis Ag | Human antibodies against il-13 and therapeutic uses |
| WO2014074682A1 (en) | 2012-11-07 | 2014-05-15 | Somalogic, Inc. | Chronic obstructive pulmonary disease (copd) biomarkers and uses thereof |
| AR098155A1 (es) * | 2013-10-23 | 2016-05-04 | Genentech Inc | Métodos para diagnosticar y tratar trastornos eosinofílicos |
| JP6871948B2 (ja) | 2016-04-27 | 2021-05-19 | アッヴィ・インコーポレイテッド | 抗il−13抗体を使用する、il−13活性が有害である疾患の治療方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9609771A (pt) | 1995-07-21 | 1999-12-21 | Trinity College Dublin | Processo para medição quantitativa de proteìna amilóide a; proteìna recombinante; anti-soro especìfico de soro humano de fase aguda. |
| US5853697A (en) * | 1995-10-25 | 1998-12-29 | The United States Of America, As Represented By The Department Of Health & Human Services | Methods of treating established colitis using antibodies against IL-12 |
| JP4155561B2 (ja) | 2000-12-26 | 2008-09-24 | 国立大学法人佐賀大学 | アレルギー性疾患検査方法 |
| JP2004121218A (ja) * | 2002-08-06 | 2004-04-22 | Jenokkusu Soyaku Kenkyusho:Kk | 気管支喘息または慢性閉塞性肺疾患の検査方法 |
| US20050036951A1 (en) * | 2003-01-09 | 2005-02-17 | Arizeke Pharmaceuticals, Inc. | Methods of treating lung diseases |
| WO2006124451A2 (en) | 2005-05-11 | 2006-11-23 | Centocor, Inc. | Anti-il-13 antibodies, compositions, methods and uses |
-
2006
- 2006-09-29 EP EP06815683A patent/EP1943359B1/de not_active Not-in-force
- 2006-09-29 WO PCT/US2006/037856 patent/WO2007041219A2/en not_active Ceased
- 2006-09-29 AT AT06815683T patent/ATE514793T1/de not_active IP Right Cessation
- 2006-09-29 US US11/536,704 patent/US7875427B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1943359A2 (de) | 2008-07-16 |
| EP1943359B1 (de) | 2011-06-29 |
| HK1123073A1 (en) | 2009-06-05 |
| US20070077585A1 (en) | 2007-04-05 |
| US7875427B2 (en) | 2011-01-25 |
| WO2007041219A2 (en) | 2007-04-12 |
| WO2007041219A3 (en) | 2007-10-04 |
| EP1943359A4 (de) | 2009-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1869462A4 (de) | Biomarker für ovarialkrebs und endometriumkrebs: hepcidin | |
| DE602006001278D1 (de) | Messinstrument für Oberflächenprofile | |
| ATE424904T1 (de) | Bausatz für komplexe konstruktionen | |
| DE602006015521D1 (de) | Messstreifen und verfahren für lateralfluss-testvorrichtungen | |
| DE602006003488D1 (de) | Einführeinrichtung für ein Instrument | |
| DE602005016173D1 (de) | Verfahren und Anordnung für einen erweiterten Verzeichnisdienst | |
| EP1901654A4 (de) | Messinstrument für perkutane operationen | |
| DE602006017421D1 (de) | Screening-verfahren für kokumi-vermittelnde agentien | |
| DE602005009994D1 (de) | Kalibration für Mixed Reality | |
| EP1838732A4 (de) | Biomarker für melanome | |
| ATE449193T1 (de) | Verfahren zur bestimmung der kopienummer | |
| DE602006009202D1 (de) | Formmessgerät | |
| AR059096A1 (es) | Anticuerpos anti- efrina -b2 y metodos que usan estos | |
| DE602005005924D1 (de) | Einheitliches Datenformat für Messgeräte | |
| DE602005016800D1 (de) | Hif-prolylhydroxylase-aktivitätstest | |
| DE602005011351D1 (de) | Reflexarme Kammer für Funkwellen mit einem verbesserten Prüfstand | |
| EP2300624A4 (de) | Biomarker für schmerzhafte bandscheiben und verwendungsverfahren dafür | |
| DE602006005208D1 (de) | Tonerzusammensetzung und Verfahren | |
| DE602005003146D1 (de) | Polymer- Zusamensetzungen für verbesserte Materialien | |
| DE602006015887D1 (de) | Wiederaufnamesystem für Luftschiffe | |
| ATE514793T1 (de) | Zusammensetzungen und verfahren für il13- biomarker | |
| ATE551605T1 (de) | Verfahren und vorrichtungen zur erkennung von biofilmen | |
| DE602005003637D1 (de) | Dichtung für Dämpfer | |
| DE502005010620D1 (de) | Obergurtquerschnitt für Kranteleskopteile | |
| EP2403843A4 (de) | Chemilumineszente zusammensetzungen, verfahren, tests und kits für oxidative enzyme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |